Tremelimumab Biosimilar - Research Grade

Tremelimumab Biosimilar - Research Grade, Host: CHO Cells, Human IgG2 kappa
Artikelnummer
ICH5184-20MG
Verpackungseinheit
20mg
Hersteller
Ichorbio

Verfügbarkeit: wird geladen...
Preis wird geladen...
Target: CTLA-4.

Specificity: Detects human CTLA-4.

Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Background: Uses the same sequence as the therapeutic antibody Tremelimumab.

Concentration: 5mg/ml.

Formulation: Sterile, preservative-free, solution in PBS. BSA and Azide free.

Purity: ≥95% monomer by analytical SEC, >95% by SDS Page.

Endotoxin: <1EU/mg Determined by LAL gel clotting assay.

Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Mehr Informationen
Artikelnummer ICH5184-20MG
Hersteller Ichorbio
Hersteller Artikelnummer ICH5184-20MG
Verpackungseinheit 20mg
Mengeneinheit STK
Reaktivität Human
Klonalität Monoclonal
Methode Functional Assay
Isotyp Human IgG2 kappa
Wirt Cell Line
Produktinformation (PDF) Download
MSDS (PDF) Download